should i microdose glp-1 medications are changing how people think about weight loss, diabetes care and even cravings. Now, more people are talking about “microdosing” GLP-1s. That usually means taking less than the typical prescribed GLP-1 Microdosing 2026: 0.1mg Chart

From GLP-1 to New Horizons: Pharma's Obesity Revolution Obesity is no longer a niche concernits a global epidemic with staggering implications

Clinical trials of GLP-1 receptor agonists have shown average reductions in daily energy intake of roughly 2030% during early treatment phases , reflecting the combined effects of increased satiety and reduced food preoccupation

Cause-specific mortality in gout: novel findings of elevated risk of non-cardiovascular-related deaths

START YOUR BASELINE Most of what we write about here shows up in your blood work

[8] [9] [10] [11] Although reduced GLP-1 secretion has previously been associated with attenuated incretin effect in patients with type 2 diabetes, further research indicates that GLP-1 secretion in patients with type 2 diabetes does not differ from healthy subjects

Additionally, healthcare providers may not be fully updated on the latest clinical evidence supporting the use of these therapies, limiting their recommendation to patients